Plexus director sells 500 shares under 10b5-1 plan
Plexus Corp director Karen Marie Rapp sold 500 shares of common stock in an open-market transaction at $270.00 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Plexus Corp director Karen Marie Rapp sold 500 shares of common stock in an open-market transaction at $270.00 per share. The trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 2, 2026. Following this sale, she directly holds 8,035 Plexus shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $.01 par value | 500 | $270.00 | $135K |
Footnotes (1)
- F1. Shares were sold pursuant to a Rule 10b5-1 plan adopted on February 2, 2026.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
open-market sale financial
Common Stock, $.01 par value financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Plexus Corp (PLXS) disclose for Karen Marie Rapp?
Was the Plexus Corp (PLXS) insider sale made under a Rule 10b5-1 plan?
What type of transaction code appears in the Plexus Corp (PLXS) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.